Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq

Ali Al-Jumaili,1 Haider N Dawood,2 Delan Ikram,3 Ali Al-Jabban3 1Pediatric Department, Central Pediatric Teaching Hospital, Baghdad, Iraq; 2Internal Medicine Department, Al-Imamain Al-Kadhimin Medical City, Baghdad, Iraq; 3Medical Department, Pfizer, Baghdad, IraqCorrespondence: Delan Ikram, Medical...

Full description

Bibliographic Details
Main Authors:	Al-Jumaili A, Dawood HN, Ikram D, Al-Jabban A
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-05-01
Series:	International Journal of General Medicine
Subjects:	pneumococcal disease streptococcus pneumoniae pneumococcal pneumonia pneumococcal vaccines pneumococcal disease-prevention strategies iraq
Online Access:	https://www.dovepress.com/pneumococcal-disease-global-disease-prevention-strategies-with-a-focus-peer-reviewed-fulltext-article-IJGM

Similar Items

Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development [version 2; peer review: 2 approved]
by: Ahmed H. Radhi, et al.
Published: (2023-12-01)

Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
by: Salini Mohanty, et al.
Published: (2023-01-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Increased Invasive Pneumococcal Disease, North East England, UK
by: Catherine Houseman, et al.
Published: (2017-01-01)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019-04-01)

Long-term trends in invasive pneumococcal disease in Manitoba, Canada
by: Salaheddin M. Mahmud, et al.
Published: (2017-08-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
by: Idrissa Diawara, et al.
Published: (2015-11-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009–2011
by: Roger R. Fan, et al.
Published: (2016-11-01)

Eventos adversos após vacinação contra o pneumococo Adverse events after pneumococcal vaccination
by: Maria Rita Donalisio, et al.
Published: (2007-02-01)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
by: Jacob Dag Berild, et al.
Published: (2020-04-01)

One year period of invasive pneumococcal disease in children from a tertiary care hospital in Turkey in the post-vaccine era
by: Gulnihan Ustundag, et al.
Published: (2021-05-01)

Economic aspects of hospital treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia
by: Adžić Tatjana, et al.
Published: (2008-01-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)

A brief history of and future prospects for pneumococcal vaccination in Malaysia
by: Alex J. J. Lister, et al.
Published: (2023-08-01)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
by: Brita Askeland Winje, et al.
Published: (2021-08-01)

Enfermedad neumocócica invasiva en niños menores de 60 meses, antes y después de la introducción de la vacuna conjugada 13-valente
by: Johanna Martínez-Osorio, et al.
Published: (2022-06-01)

Serotype Distribution and Antimicrobial Susceptibility Pattern of <i>Streptococcus pneumoniae</i> in COVID-19 Pandemic Era in Brazil
by: Samanta C. G. Almeida, et al.
Published: (2024-02-01)

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines
by: Echániz-Avilés Irma Gabriela, et al.
Published: (2001-01-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)

Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines
by: Kozlov R.S., et al.
Published: (2020-12-01)

Recent progress in pneumococcal protein vaccines
by: Sha Li, et al.
Published: (2023-09-01)

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
by: Germaine Hanquet, et al.
Published: (2022-01-01)

Pneumococcal Disease Prevention: Are We on the Right Track?
by: Nicola Principi, et al.
Published: (2021-03-01)

Adult pneumococcal vaccination – new opportunities
by: ERNEST KUCHAR, et al.
Published: (2023-03-01)

Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016
by: Shoji H, et al.
Published: (2018-09-01)

Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
by: I. Rivero-Calle, et al.
Published: (2020-06-01)

Antimicrobial Resistance in <i>Streptococcus pneumoniae</i> before and after the Introduction of Pneumococcal Conjugate Vaccines in Brazil: A Systematic Review
by: Patricia Alice Knupp-Pereira, et al.
Published: (2024-01-01)

Acute heart failure due to invasive pneumococcal disease and purulent pericarditis: A case report
by: Gregorio Tersalvi, et al.
Published: (2021-01-01)

Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study
by: Ma-Chao Li, et al.
Published: (2021-01-01)

Pneumonia: Regional experience with prevention programs
by: A G Chuchalin, et al.
Published: (2016-08-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01)

Pneumococcal Meningitis in Children: Evaluation of 46 Cases
by: Ayper SOMER, et al.
Published: (1999-06-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
by: Nobuhiro Asai, et al.
Published: (2021-11-01)

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
by: Jennifer L. Farrar, et al.
Published: (2023-05-01)